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CHAPTER 1 
Introduction 
	   2 
The consumption of fermented milk has been associated with beneficial health 
effects. A century ago, Elie Metchnikoff (a Russian scientist, Nobel laureate) 
postulated that the foods such as yogurt, kefir, and sour milk containing lactic acid 
bacteria offered health benefits capable of promoting longevity. He reported that 
Bulgarian peasants who consumed large quantities of Bulgarian sour milk lived 
longer (1). Henry Tissier, in parallel with Metchnikoff, first isolating bifidobacteria 
from a breastfed infant, proposed that bifidobacteria might be effective in preventing 
infections in infants, due to their predominant existence of the intestinal microflora of 
breastfed infants (2). The works of Metchnikoff and Tissier were the first to make 
people concerning the probiotic use of bacteria, even if the word “probiotic” was not 
yet created. After their findings, the studies of the beneficial effects on the host by the 
consumption of microorganisms has been started to develop. 
Probiotics, the term first introduced by Lilly and Stillwell in 1965, were defined as 
growth-promoting factors produced by microbes that stimulate the growth of other 
organisms, in contrast to antibiotics (3). In 1989, probiotics were redefined by Roy 
Fuller as living bacteria that have beneficial effects on the host by improving the 
balance of microflora in the intestine (4), which has been broadened to state that “a 
probiotic is a mono- or mixed culture of live microbes which, when applied to animal 
or man, affect the host beneficially by improving the properties of the indigenous 
microflora” (5). However, the definition of probiotics has been changed in these years. 
In 2001, a joint Food and Agriculture Organization of the United Nations/World 
Health Organization (FAO/WHO) expert consultation on health and nutritional 
properties of powder milk with live lactic acid bacteria redefined probiotics as “live 
microorganisms which when administered in adequate amounts confer a health 
benefit on the host“, pointing the importance of the viability and an adequate dose of 
	   3 
probiotic bacteria in order to exert the desirable effects (6). However, many studies 
indicated that the dead cells of probiotics also generate beneficial biological responses, 
while the components of dead cells induce an anti-inflammatory response in the host 
intestine (7). Since the use of dead probiotics has several attractive advantages (e.g. 
safety and long shelf-life), redefinition or a new definition would be needed for the 
coming products of probiotics in the future. 
Some desirable characteristics of probiotic microorganisms were described, such 
as: 
1. Human origin 
2. Generally recognized as safe (GRAS) status 
3. Nonpathogenic and noninflammatory 
4. Resistance to low pH and bile salts 
5. Adhesion to the host gut and proliferation 
6. Survival in association with the mucosal immune system 
7. Immunostimulatory for the mucosal immune system 
8. Technological suitability and so on (8).  
Nowadays, probiotics are of significant importance to food and health industries 
due to their health-promoting effects when consumed. Species of Lactobacillus and 
Bifidobacterium are most commonly used as probiotics. Studies have documented 
probiotic effects on dysbiosis (9), acute diarrhea (10), inflammatory bowel disease 
(IBD), irritable bowel syndrome (IBS), colon cancer (11), vaginal infection (12), 
allergy (13), and eradication of Helicobacter pylori (14). For the purpose of being 
sufficient host-interaction to confer health benefits, adhesion ability to the host gut 
has been considered as one of the selection criteria for probiotic strains. After oral 
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consumption, probiotics are believed to temporarily colonize the host intestine by 
adhering to intestinal surface. 
The gastrointestinal (GI) epithelium is always exposed to digestive enzymes, fecal 
material, microorganisms and their products in lumen. There is a layer of mucus 
lining on the GI tract, which plays an important role in lubricating and protecting the 
epithelium from mechanical and chemical stress. The mucus layer is the first line 
against luminal substances, especially the commensal bacteria and invading 
pathogens, providing a physical and semi-permeable barrier between the epithelium 
and the contents of lumen. The thickness of the layer is around 400 µm in the intestine 
(15), which contains 2 layers (16). The thinner inner mucus layer is difficult to 
dislodge, whereas the outer layer mainly consists of secreted mucins, nonspecific 
antimicrobials and specific antimicrobial immunoglobulins (17). 
Mucins, the major protein components of the mucus, are glycoproteins with high 
molecular weight from 0.5 × 106 Daltons to 25 × 106 Daltons. The secretion is mainly 
by goblet cell but also by epithelium cell in the GI tract (18). The formation of mucin 
starts in endoplasmic reticulum with the production of the protein backbones, which 
comprises tandem repeats rich in threonine, serine and/or proline residues. After that, 
the oligosaccharides are highly attached to the variable number tandem repeats 
(VNTR) of the backbones by O-linked glycosylation range from 1 to more than 20 
residues in the Golgi apparatus (Fig. 1-1). Moreover, N-acetylneuraminic acid 
(Neu5Ac, the predominant sialic acid found in mammalian cells) and sulfate residues 
are added to the end of the oligosaccharides. The oligosaccharide structures can be 
linear or branched, and acidic or neutral in nature, which shows a huge variation in 
different parts of GI tract (19, 20).  
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Based on different protein cores encoded from human genome, mucin could be 
divided into over 20 types (19). In human GI tract, there are about 7 kinds of mucin 
existed, and MUC2 mucin is the predominant secretory and gel-forming mucin, which 
is specifically secreted by goblet cells (Table 1-1). MUC2 gene has been mapped to 
chromosome 11p15, and is a highly repetitive gene (21). In the tandem repeat domain, 
approximately 78% of the threonine is glycosylated, which involved in its gel-
forming characteristic. After exocytosis, MUC2 mucin may bind to each other and 
become oligomer via disulfide bond (22). Additionally, the human genome encodes at 
least four gel-forming mucins, but MUC2 is the only gel-forming mucin and a major 
component in the mucus of human intestine, and only expressed in goblet cells in 
intestine (23). 
The carbohydrate part of mucin can constitute at least 70% of the total mass and 
provide many necessary properties, such as protease resistance and water-holding 
capacity (24). The sugar chains of mucin are attached to the core protein via an O-
glycosidic linkage between a serine (or threonine) residue and an N-acetyl-
galactosamine (GalNAc) residue (25). Despite the heterogeneity of the mucin sugar 
chain is extremely large, there are main structural features of O-glycan found in 
intestinal mucin. The sugar chains can be divided into 3 separate regions, which are 
core structure, type chain and terminal structure (Fig. 1-2). There are over 8 types of 
core structure have been found in human, but only 5 expressed in the intestine (Table 
1-2). The predominant core structure of mucins in every part of the intestine from 
adults is core 3 (26), whereas the fetal mucin is mainly based on core 2 structures (27). 
After the repeated type chain, the terminal region is made up of saccharides (e.g. 
blood group antigen) or acidic residues (Neu5Ac and sulfate) (28). 
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Along the human intestine, mucin was found to become more and more acidic, and 
contain less fucose residues. In the ileum, about 30% of mucin oligosaccharides are 
acidic, but in the distal part more than 65% contain acidic residues (29). According to 
recent studies, NeuAc residues were mainly α2-6 linked to the GalNAc, and the 
sialylated core 3 structures were covered in all parts of intestine. On the other hand 
sulfate was essentially 3-linked to Gal or 6-linked to GlcNAc residues, which sulfated 
glycans were mainly recovered in distal colonic mucins (26, 29). 
The acidomucin in the colon is proposed to protect against enzymatic digestion 
from high concentrations of bacteria (30). Sulfation of mucin confers resistance to 
enzymic degradation of the mucus barrier by bacterial glycosidases (31), and sialic 
acid has been implicated in the protease inhibition by mucins (32). Intestinal 
infections and the development of experimental colitis using dextran sulfate sodium in 
mice increased by knocking out the intestinal sulfate transporter; and showed the 
protective function offered by sulfomucins in vivo (33, 34). Some studies indicate an 
alteration of mucin chemotype usually comes with changes in microflora and 
intestinal inflammation. For example, the expression of acidomucin was different in 
IBD where the sulfation of mucins was decreased (35) and the expression of 
sialomucin was increased (36). The interaction between acidomucin and microflora 
remains unclear; however, there is a positive correlation between the expressed 
proportion of sulfomucin and sulfate-reducing bacteria, which can use sulfate from 
sulfomucin for sulfate respiration in the intestine (37, 38). Other microflora bacteria 
showed the degradation ability by expression of glycosulfatase specifically for human 
gastric (39) and oral mucin (40).  In addition to a source of nutrients, mucin also 
serves as binding sites for microbes. Bacteria adhering to the core protein (41), sugar 
chains, and terminal residues (including blood group antigens, sialic acid and sulfate) 
	   7 
in the mucin structure (42, 43) was reported. However, few studies have been 
conducted to investigate the binding between microbes and the acidic sugar residues 
(44-46); and therefore there is a lack of clarity about interactions between probiotics 
and acidomucins. 
Accordingly, for the purpose of investigating the adhesion of probiotics to acidic 
residues in human colonic mucin, a new evaluation system for screening probiotics 
with adhesive properties to Neu5Ac and sulfate residues was constructed using the 
Biacore adhesion assay in the next chapter. After that, the adhesion properties of the 
selected probiotics were further investigated in chapter 3, and the detection and 
identification of adhesin-like components with specific affinity to sulfate residue were 
performed in chapter 4. Since the acidic residues are possible adhesion site for 
inflammatory pathogens, the results in this study would be expected to provide hints 
for curing the bowel disease related to altered glycosylation. 
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“About Biacore” 
Biacore is a system for real-time biomolecular interaction analysis. It monitors the 
formation and dissociation of biomolecular complexes on a sensor surface as the 
interaction occurs. By covalently attaching one molecule (ligand) to the surface, the 
interaction of another molecule in solution (analyte) with the ligand is followed. 
Measurements are made under conditions of continuous flow. For the majority of 
applications, the biospecific surface can be regenerated and reused for an extended 
series of analyses. 
The measurement in Biacore is performed using surface plasmon resonance (SPR). 
SPR is a non-invasive optical measuring technique which measures the mass 
concentration of biomolecules in close proximity to a specially prepared surface (Fig. 
1-3). The technique does not require any labeling of the interacting components. The 
response is essentially independent of the nature of the biomolecule, so that all steps 
in an interaction analysis may be followed with the same detection technique. 
In a Biacore adhesion aasay, the following steps are proformed. A sensorgram is a 
plot of response against time (Fig. 1-4), showing the progress of the interaction. After 
the ligand immobilized on a sensor chip, the solution of analyte can be injected to the 
selected flow cell. When the injection of analyte stops, the buffer from the system will 
start to flow. The adhesion value should be observed in this step (Fig. 1-5). Finally, by 
an injection of acidic (glycine-HCl buffer or dilute HCl), basic (NaOH) or surfactant 
solutions, the bound analyte should be removed from the sensor chip surface without 
destroying the ligand activity. The process here is called regeneration. The number of 
times a sensor surface can be regenerated depends on the nature of the attached ligand, 
but is usually greater than 100 and may even be 1000 or more. Time spent on the 
adhesion assay would be about 20 min one time. The amount of ligand and analyte is 
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not constant in every test. For most proteins, concentrations of 10-50 µg/mL are 
sufficient, and higher concentrations simply consume more ligand without 
significantly improving the results. Lower concentrations may be used in favorable 
cases. The analyte concentration is around 1-3 mg/mL in this study. 
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Figure 1-1. The Structure of MUC1 and MUC2 (20). 
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Table 1-1. Different types of mucin in intestinal tract of human, including 
large and small intestine (23). 
Gene Type Expression 
MUC1 Membrane-associated Mammary gland, cervix, pancreas, lung, 
large intestine 
MUC2 Secretory Small intestine, large intestine, respiratory 
tract 
MUC3 Membrane-associated Small intestine, large intestine, 
gallbladder, lung 
MUC4 Membrane-associated Large intestine, stomach, mammary 
gland, cervix, lung 
MUC12 Membrane-associated Large intestine, pancreas, prostate, cervix 
MUC13 Membrane-associated Large intestine, respiratory tract, kidney, 
small intestine, stomach 
MUC21 Membrane-associated Lung, thymus, large intestine 
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Figure 1-2. The representative structure of the oligosaccharides in 
intestinal mucin which is based on the core 3 structure with type chain 
and blood type A antigen (26, 47). 
	   13 
 
 
 
 
 
 
 
 
Table 1-2. Oligosaccharide epitopes on intestinal mucin O-glycans (48). 
Epitope Core structures 
Core 1 Galβ1-3GalNAc 
Core 2 GlcNAcβ1-6 (Galβ1-3) GalNAc 
Core 3 GlcNAcβ1-3GalNAc 
Core 4 GlcNAcβ1-6 (GlcNAcβ1-3) GalNAc 
Core 5 GalNAcα1-3GalNAc 
 Type chain 
Type 1 -Galβ1-3GlcNAcβ1- 
Type 2 -Galβ1-4GlcNAcβ1- 
 Terminal structures 
Blood group H Fucα1-2Galβ1- 
Blood group A GalNAcα1-3 (Fucα1-2) Galβ1- 
Blood group B Galα1-3 (Fucα1-2) Galβ1- 
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Figure 1-3. A ligand-analyte interaction of Biacore analysis using 
surface plasmon resonance. 
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Figure 1-4. A typical sensorgram of Biacore and the interpretation. 
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Figure 1-5. Outline of Biacore apparatus 
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CHAPTER 2 
New screening methods for probiotics with adhesion 
properties to acidic residues in human colonic mucin 
using the Biacore assay 
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Introduction 
Mucin is the major component of the intestinal mucus layer, and can be divided 
into neutral and acidic mucin. Acidic mucin is further classified into sialomucin with 
sialic acid (N-acetylneuraminic acid, NeuAc) and sulfomucin with sulfate residues 
that bind to the sugar chain of mucin. The binding position of these acidic residues is 
limited in human intestinal mucin where they link to specific positions on the sugar 
chain. Sialic acid residues expressed in mucin were found primarily α2-6 linked to the 
initial N-acetylgalactosamine (GalNAc) and to a lesser extent α2-3 linked to the 
terminal galactose (Gal). Sulfate residues were primarily linked to the C-3 of terminal 
Gal or less so to the C-6 of N-acetylglucosamine (GlcNAc) (Fig. 2-1, based on Robbe 
et al.) (29). The expression of sialomucin and sulfomucin increases gradually along 
the human colon where sulfomucin is predominant (38). Since increased bacterial 
concentrations were also observed in descending colon, the acidic residues are 
proposed to protect colon mucin against enzymatic digestion from microflora (30). 
Few papers report the interaction between acidomucin and microflora; some assays 
were used in measuring the binding between them. The most commonly used method 
is the microplate assay. After immobilization of mucin on the plate, enzymatic 
cleavage or chemical treatment can be performed before adding target bacteria or the 
surface component (49). Conversely, when bacteria or the surface component is 
immobilized on the plate, adding desialylated or desulfated mucin to measure the 
remaining adhesion was investigated (45). Immunodetection by dot blot analysis was 
used. Using desialylation or desulfation of biotinylated mucin, the binding of bacterial 
components to acidomucin was observed qualitatively (46). However, the microplate 
assay is a quantitative and efficient method requiring many artificial operations that 
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may introduce error in the experiment. A sensitive, quantitative analysis method with 
fewer artificial operations was required. Therefore, a modified binding assay using 
Biacore was developed for evaluating the adhesiveness of lactobacilli and 
bifidobacteria to sialic acid and sulfate residues of mucin.  
In the previous studies using the Biacore adhesion assay, several Lactobacillus 
species isolated from the human intestine was found to bind to the human blood group 
A and B antigens of human colonic mucin (HCM). Furthermore, the adhesins from 
lactobacilli, e.g. the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ATP-
binding cassette (ABC) transporter expressed on the surface of bacteria were 
identified and characterized (43, 50). Using chemical and enzymatic modification of 
mucin with the Biacore adhesion assay, here I describe a new screening method to 
evaluate the specific adhesion of probiotics for sialic acid and sulfate residues in 
intestinal mucin. The removal of sialic acid and sulfate residues were performed using 
sialidase and sulfatase, respectively. Blockage of sulfate was performed by elution 
with barium chloride using the Biacore assay. Additionally, some improvements in 
the HCM purification procedure were made. Because there is a relationship between 
the expression of mucin chemotypes, microflora and intestinal inflammation, building 
an evaluation system to clarify the binding of acidomucin and microorganisms may 
be helpful to understand the adhesion strategies of bowel disease pathogens and 
microflora in the digestive tract. 
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Figure 2-1. Representative binding position of N-acetylneuraminic acid 
(NeuAc) and sulfate (SO3-) on the sugar chain of human colonic mucin 
(based on Robbe et al. 2004).  Since the sugar chain expressed in 
human intestinal mucin could be shorter or longer with different 
compositions, this figure only shows the possible binding sites of the 
acidic residues. 
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Materials and Methods 
1. Bacterial strains and culture 
Ten strains of lactobacilli and three strains of bifidobacteria were used for the 
adhesion assay in this study (Table 2-1). Lactobacilli were provided from the culture 
collection of Meiji Co., Ltd. (Tokyo, Japan); and bifidobacteria was a gift from 
Morinaga Milk Industry Co., Ltd. (Zama, Japan). All strains were isolated from 
human feces. Lactobacilli strains were grown in Man Rogosa Sharpe (MRS) broth 
(Difco Laboratories, Detroit, MI); and propagated twice at 37 °C for 16 h with a 2% 
(v/v) inoculum. Bifidobacteria strains were cultured anaerobically in GAM broth 
(Nissui Seiyaku, Tokyo, Japan) twice at 37 °C for 24 h with a 10% (v/v) inoculum. 
Bacterial cells were collected from the culture medium using centrifugation (8500 × g, 
4 °C, 10 min) and washed three times with phosphate-buffered saline (PBS, pH 7.4). 
After removing the media components, the bacterial cells were lyophilized. Before 
using the Biacore assay, the cells were suspended in HBS-EP buffer (HEPES-
buffered saline with EDTA and polysorbate 20: 0.01 M HEPES, pH 7.4, 0.15 M NaCl, 
3 mM EDTA, 0.005% surfactant P20; GE Healthcare Bio-Sciences K.K., Tokyo, 
Japan) as the analyte (3 mg/mL) in the Biacore assay. 
 
2. Purification of soluble human colonic mucin 
This study was approved by the ethics committee of Tohoku University Graduate 
School of Medicine. Human colon mucus was obtained from Tohoku University 
Graduate School of Medicine. Crude mucus was scraped from the normal intestinal 
tissues of colorectal cancer patients; and extracted with chloroform: methanol (2:1, 
v/v) and diethyl ether three times respectively to remove lipid. The lipid-free HCM 
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was digested with 0.5 mg/mL Proteinase K (TaKaRa Biotechnology, Shiga, Japan) 
overnight. After centrifugation (8500 × g, 4 °C, 10 min) and membrane filtration 
(DISMIC-25, 0.45 µm, Advantec, Tokyo, Japan), the supernatant was purified by gel 
filtration chromatography with a Toyopearl HW-65F column (90 × 2.6 cm; Tosoh, 
Tokyo, Japan) using distilled water as the mobile phase. Peptide was detected at 214 
nm and neutral sugar was measured at 490 nm using the phenol-sulfuric acid method. 
Fractions containing high concentrations of sugars and peptides were collected and 
concentrated before lyophilization. The purified soluble HCM (sHCM) was used as 
the ligand for the Biacore analysis.  
 
3. Immobilization of sHCM 
All Biacore experiments were performed using a Biacore 1000 (GE Healthcare 
Bio-Sciences K.K.) at 25 °C in HBS-EP buffer. The immobilization of sHCM on a 
CM5 sensor chip (GE Healthcare Bio-Sciences K.K.) was an amine coupling reaction 
following the manufacturer’s instructions. sHCM was dissolved at 10 mg/mL in 10 
mM sodium acetate buffer (pH 4.0) and immobilized using the reaction between N-
hydroxysuccinimide (NHS) -esters and radicals of primary amino groups in sHCM. 
The sensor chip was equilibrated in HBS-EP buffer. 
 
4. Removal of sialic acid from sHCM 
The removal method of sialic acid was the modified van der Merwe et al. method 
(51). After immobilization onto Biacore CM5 sensor chips, sHCM was desialylated 
by injection of 100 mU/mL Streptococcus Neuraminidase F (Seikagaku Co., Tokyo, 
Japan), enzymatically removing α2-3, α2-6, and α2-8 linked sialic acid (used as 
sialidase in this study) in 10 mM citrate phosphate buffer (pH 6.5) with 2 mM CaCl2 
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at a flow rate of 1 µL/min at 25 °C	  for 12.5 h; and then equilibrated in HBS-EP buffer 
(Fig. 2-2).  
 
5. Removal and blocking of sulfate groups in sHCM 
The desulfation method was modified from Fong et al. (52) and performed in test 
tubes. sHCM was treated with 2 U/mL Helix pomatia sulfatase (Sigma-Aldrich, MO, 
USA) in 100 mM sodium acetate buffer (pH 5.0) overnight at 37 °C using a sham 
digestion control with boiled enzyme. The enzymatic reaction was terminated by 
boiling for 15 min. After dialysis of treated sHCM against 10 mM sodium acetate 
buffer (pH 4.0) for 6 h at 4 °C, the dialysates were immobilized onto Biacore CM5 
sensor chips following the manufacturer’s instructions. Further, the mucin-binding 
sulfate residues on the sensor chip-bound sHCM were blocked using injection of 0.5 
M barium chloride (Wako Pure Chemical Industries, Ltd., Osaka, Japan) at a flow rate 
of 1 µL/min for 12.5 h; and then equilibrated in HBS-EP buffer (Fig. 2-2). 
 
6. Probiotics and lectin adhesion analysis using Biacore 
Quantifying adhesion using the Biacore 1000 is based on the principle of surface 
plasmon resonance (53). After washing and lyophilization, bacterial cells were 
suspended at a concentration of 3 mg/mL in HBS-EP buffer. After injecting the 
bacteria suspension at a flow rate of 3 µL/min for 5 min, the sensor chip was washed 
with HBS-EP buffer to remove unbound analyte; and regenerated eluting with 1 M 
guanidine hydrochloride (GHCl) solution at a flow rate of 3 µL/min for 2 min. The 
resonance units (RU) were measured for 200 s after the cessation of sample addition. 
For quantifying the adhesion of lectins to sHCM, Erythrina cristagalli Agglutinin 
(ECA, J-OIL MILLS, Inc., Tokyo, Japan) and Arachis hypogaea (peanut) Agglutinin 
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(PNA, J-OIL MILLS) were dissolved at 1 mg/mL in HBS-EP buffer and injected to 
CM5 sensor chip at a flow rate of 3 µL/min for 15 min. The measurement of RU and 
other experimental steps were performed following the steps in bacteria adhesion 
assay above. A response of 1 RU represents about 1 pg/mm2 protein adhering with 
increased concentration of analyte bound to the sensor chip surface. 
 
7. Statistical analysis 
All experiments were performed in triplicate and reported as the mean ± SD. For 
adhesion test between sHCM and bacterial cells using the Biacore assay, statistical 
analysis of the data was performed using one-way analysis of variance (ANOVA test) 
followed by the post hoc Dunnet test when the F value showed significant differences 
at p < 0.05. For adhesion tests between desulfated (or desialylated) sHCM and 
bacterial cells using the Biacore assay, statistical analysis of the data was performed 
using the Student’s t-test. For each statistic, significant differences were inferred 
whenever the p-value was <0.05. 
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Table 2-1. Lactobacilli and bifidobacteria used in this study 
Bacterial species Strain Source 
Lactobacillus gasseri OLL2716 Human feces 
Lactobacillus brevis OLL2772 Human feces 
Lactobacillus brevis OLL2775 Human feces 
Unidentified Lactobacillus species OLL2785 Human feces 
Lactobacillus gasseri OLL2793 Human feces 
Lactobacillus gasseri OLL2804 Human feces 
Lactobacillus gasseri OLL2827 Human feces 
Lactobacillus mucosae OLL2855 Human feces 
Lactobacillus gasseri OLL2877 Human feces 
Lactobacillus mucosae OLL2882 Human feces 
Bifidobacterium breve MCC167 Infant feces 
Bifidobacterium bifidum MCC1092 Adult feces 
Bifidobacterium infantis ATCC15697 Infant feces 
 
The strains were identified through API 50CHL analytical system and 
16S rRNA analysis. 
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Figure 2-2. The illustration of sHCM treated with sialidase, sulfatase, and 
barium chloride. 
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Results 
1. Purification of soluble human colonic mucin 
In the previous study (54), the de-lipid mucus was dissolved in 4 M GHCl, 
fractionated it using gel filtration chromatography and collected the fractions 
containing high sugar and protein concentrations to obtain the purified human colonic 
mucin (HCM). However, there were some proteins (e.g. human histone H3) found in 
the HCM that have binding activities for probiotics (55). To analyze the adhesion 
between the mucin sugar chain and probiotics, the mucin was further purified with 
Proteinase K to digest these proteins and the core protein structure of mucin. After gel 
filtration chromatography, the fractions containing high concentrations of sugars and 
peptides (fraction no. 24 to 84) were collected and lyophilized (Fig. 2-2). 
This allowed me to study the adhesion of the mucin oligosaccharides and the 
terminal residues. Due to its water-soluble properties, I called this soluble HCM 
(sHCM). 
 
2. Screening of probiotics binding sHCM 
Previously, some lactobacilli and bifidobacteria were found to have strong 
adhesion ability to HCM and human blood group antigens expressed in intestinal 
mucin (54, 56). Here I used 10 strains of lactobacilli and three strains of 
bifidobacteria that adhered to HCM strongly; and were selected to measure the 
adhesive activities to sHCM. Using the Biacore analysis, lyophilized bacterial cells as 
analytes were analyzed to determine their adhesion abilities to the immobilized sHCM 
as ligands. Results show there were three probiotics showing significant higher 
adhesion than others (p < 0.01) that were all under 60 RU. Lactobacillus gasseri 
OLL2877 showed the highest adherence (401.2 ± 78.6 RU) to the sHCM and the 
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adhesion activities of Lactobacillus strain OLL2785 and Bifidobacterium bifidum 
MCC1092 strains were 225.5 ± 90.5 RU and 196.3 ± 40.4 RU, respectively (Fig. 2-4). 
Thus, the three bacterial strains were selected to investigate further the adhesion 
mechanism of human colonic acidomucin. 
 
3. Probiotics recognize sialic acid on sHCM 
After screening the probiotics with higher adhesion activities to sHCM, I analyzed 
whether the probiotics bound to sialic acid or sulfate residues of mucin 
oligosaccharides. Using Biacore analysis, sHCM was immobilized onto a Biacore 
sensor chip CM5 and the sialic acid expressed in sHCM was removed by elution with 
sialidase overnight on the Biacore biosensor. With sialidase, the α2-3 and α2-6 linked 
sialic acid binding to sHCM was cleaved, and the peripheral galactose and the initial 
GalNAc would presumably be exposed. Therefore, the binding value for PNA lectin 
for sHCM increased significantly after sialidase treatment (p < 0.001), since PNA 
lectin recognizes and binds to the carbohydrate sequence Galβ1-3GalNAc (Fig. 2-5).  
After sialidase treatment, the resonance units of the three selected bacteria strains 
were decreased significantly (p < 0.05). The adhesion of OLL2785 strain showed a 
7.4-fold decrease, the highest among the three probiotics (Fig. 2-6). This showed the 
sialic acid expressed in sHCM could be recognized by the three selected bacteria 
strains and may serve as binding site for the microbes in the intestine. 
 
4. Probiotics recognize sulfate residue on sHCM 
The effects of removing sulfate residues on probiotic adhesion were determined. I 
tried in a similar way to remove sulfate on sHCM-immobilized CM5 sensor chips by 
elution of sulfatase overnight to remove the 3-linked or 6-linked sulfate residues 
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expressed in sHCM and disclose galactose or GlcNAc. However, I found the 
resonance unit of the sensor chip increased after the elution of sulfatase overnight, 
indicating the sulfatase bound to sHCM. To avoid the effects of binding sulfatase, 
sham digestions were performed with boiled inactive enzyme. The adhesive assay 
between probiotics and sulfatase was also performed, and the three probiotics showed 
a very low binding activity to sulfatase (under 5 RU). Compared to sham digestion 
groups, the adhesion abilities of three probiotics were different after sulfatase 
treatment. L. gasseri OLL2877 showed a significant decrease after removing sulfate 
residues in sHCM. However, the adhesion of OLL2785 strain and B. bifidum 
MCC1092 increased (p < 0.05) (Fig. 2-7). 
With sulfatase, the sulfate residue linked to the C-3 of Gal and the C-6 of GlcNAc 
was cleaved, and the terminal Gal and the GlcNAc should presumably be exposed. 
PNA and ECA lectin recognizes and binds to the carbohydrate sequence D-Gal and 
Galβ1-4GlcNAc, respectively, so I used them to confirm the treatment of sulfatase. 
However, the binding value for the lectins for sHCM decreased significantly after 
sulfatase treatment (p < 0.05) (Fig. 2-8). 
Further, the sHCM-immobilized sensor chip was treated with barium chloride to 
block the electric charge of the sulfate, a possible binding site for microbes. There 
was a significant decrease in adhesion after barium chloride treatment (p < 0.05). The 
most significant was OLL2785 strain that showed a 10.4-fold decrease (p < 0.01) (Fig. 
2-9).  
Therefore, only L. gasseri OLL2877 showed significant decrease of adhesion after 
sialidase, sulfatase or barium chloride treatment on mucin; whereas the adherence of 
OLL2785 strain and B. bifidum MCC1092 decreased after sialidase and barium 
chloride treatment and increased after sulfatase digestion. 
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Figure 2-3. The purification of soluble human colonic mucin (type A) by 
gel filtration chromatography was detected by UV absorption at 214 nm 
(peptide) and phenol-sulfuric acid method at 492 nm (neutral sugar). 
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Figure 2-4. Binding abilities of the cell bodies of lactobacilli and 
bifidobacteria isolated from human feces to sHCM using Biacore 
analysis. Columns represent the mean ± SD (n = 3). **p < 0.01. 
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Figure 2-5. The change in binding values for PNA lectin before and after 
sHCM digested by sialidase. Columns represent the mean ± SD (n = 3). 
***p < 0.001. 
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Figure 2-6. The change in adhesion values for the selected three strains 
for the sugar chain of sHCM before and after sialidase digestion. 
Columns represent the mean ± SD (n = 3). (▨) before sialidase treatment; 
(░) after sialidase treatment. *p < 0.05; **p < 0.01. 
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Figure 2-7. The change in adhesion values for the selected three strains 
for the sugar chain of sHCM before and after sulfatase digestion. 
Columns represent the mean ± SD (n = 3). (■) adhesion to sham 
digestion; (□) adhesion to sulfatase digestion. *p < 0.05. 
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(a)                                                           (b) 
 
 
Figure 2-8. The change in binding values for (a) PNA and (b) ECA lectin 
before and after sHCM digested by sulfatase. Columns represent the 
mean ± SD (n = 3). *p < 0.05. 
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Figure 2-9. The change in adhesion values for the selected three strains 
for the sugar chain of sHCM before and after BaCl2 treatment. Columns 
represent the mean ± SD (n = 3). (■) before BaCl2 treatment; (□) after 
BaCl2 treatment. *p < 0.05; **p < 0.01. 
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Discussion 
Here, I chose 10 strains of lactobacilli and three strains of bifidobacteria that 
highly bound to HCM to measure the adhesion to sHCM. However, only two 
lactobacilli strains and one bifidobacteria strain adhered to sHCM significantly 
suggesting the other ones bound to the core proteins of colonic mucin or the low-
molecular-weight proteins (e.g. histone H3) contained in the previously purified HCM. 
The adhesin Lam29 isolated from L. mucosae was demonstrated to contain specific 
affinity to human histone H3 from intestinal mucosa (55), and MUC2 was reported as 
a major chemo-attractant and binding target for Campylobacter jejuni in the host 
intestinal tract (41). These studies and the results in this study suggest the adhesion 
strategy of microflora is not constant but variable. 
Here, a sialidase treatment was performed using the Biacore assay; and the 
adhesion of three probiotic strains was decreased significantly after removing sialic 
acid from colonic mucin, suggesting the sialic acid residue was recognized as a 
binding site by these probiotics. There are some microflora and pathogens also 
reported to show adherence to sialic acid expressed in mucin. Helicobacter pylori is 
well known to contain a sialic acid-binding adhesin (Sab A) that adheres to sialylated 
glycoprotein during inflammation (57). Streptococci (45) and Escherichia coli (58) 
were also reported to colonize through sialic acid-containing receptors and 
sialoglycoprotein respectively. Pseudomonas aeruginosa, a major pathogen in cystic 
fibrosis, was shown to adhere to respiratory tissue using sialic acid-containing 
receptors on cell surfaces or in mucins (59). 
Using the Biacore assay to evaluate the interaction between selected probiotics and 
sulfate residues, L. gasseri OLL2877 showed a significant decrease after both 
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sulfatase and barium chloride treatment suggesting OLL2877 has a strong adhesion to 
the sulfate expressed in sHCM. A previous report shows mucus-binding proteins of L. 
reuteri showed significant decrease in adherence of human intestinal mucin after 
sialidase or sulfatase treatment (46). The outer membrane protein of H. pylori was 
reported to bind strongly to sulfo-Lewis a, sulfogalactose and sulfo-GlcNAc in 
salivary mucin (44); and P. aeruginosa also showed strong adherence to salivary 
mucin containing sulfated glycopeptides (59, 60). The sulfate content of colonic and 
salivary mucin are similar among the digestive tracts (30). According to these studies 
and my results, highly sulfated mucin may be a binding site for some microorganisms, 
although acidomucin has been proposed to protect the mucin from bacterial digestion. 
Some reports indicated that additional sulfated and/or sialylated polysaccharides 
suppressed the colonization of H. pylori in vitro and in vivo (61, 62). 
Although the adhesion of OLL2785 strain and B. bifidum MCC1092 decreased 
after blockage of sulfate groups, it increased after sulfatase digestion. From the 
specific binding position of sulfate groups (Fig. 2-1), OLL2785 strain and B. bifidum 
MCC1092 may have some adherence properties to sulfate. However, they may have 
more binding abilities to galactose or GlcNAc exposed after sulfatase digestion than 
to the sulfate residue. Previously, some lactobacilli were reported that strongly bound 
to blood group antigens expressed in intestinal mucosa, which implied the terminal 
sugar residues of colonic mucin may serve as binding sites for probiotics (43, 63).  
Here, a new screening method was constructed using the Biacore assay to search 
for high-adhesive probiotics to sialic acid and sulfate residues of human colonic 
mucin. Three probiotics were found that recognized sialic acid, sulfate, and/or 
terminal oligosaccharide residues of colonic mucin showing a variation in adhesion 
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strategy among microbes. Next, the adhesive properties of bacterial cell surface 
proteins from three probiotics to the sialic acid and sulfate residues were analyzed. 
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CHAPTER 3 
Analysis of surface proteins from probiotics with 
adhesion properties to acidic residues  
using the Biacore assay 
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Introduction 
In chapter 2, a new screening method was developed using Biacore adhesive assay 
to observe the binding of bacteria to the acidic residues of human colonic mucin 
(HCM). First, some procedures were added in purification of HCM to further study 
the adhesion of mucin oligosaccharides and terminal residues. The removal of acidic 
residues and blockage of sulfate were performed by enzymic and chemical treatment, 
respectively. Finally, three bacterial strains isolated from human feces with strong 
adhesion to acidic residues were selected. However, the adhesion molecules and 
adhesive properties of the strains with specific affinity to acidic residues were still 
unknown.  
The adhesive abilities of microflora to GI tract are proved to associate with their 
cell surface protein (64). In the previous studies using the Biacore adhesion assay, 
some Lactobacillus species isolated from the human intestine were found that adhered 
to the human blood group A and B antigens of HCM. The cell surface protein, e.g. the 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (43) and ATP-binding cassette 
(ABC) transporter (55) expressed on the surface of bacteria, were demonstrated to 
participate in the adhesion. There are some methods used for extraction of bacterial 
surface proteins that researcher have used are: (1) chaotropic agents like LiCl or 
guanidine, (2) detergents like SDS, (3) enzymes such as trypsin or lysozyme, or (4) 
buffers used for washing such as PBS (65).  After extraction, there are some effective 
strategies for profiling cell surface protein, e.g. using cell culture, biotinylation of 
membrane proteins, and analysis by 2-D PAGE (66). In this chapter, the PBS wash 
fractions and GHCl-extracted fractions of the selected probiotic strains were tested for 
adhesion to sHCM and the bionylated probes containing acidic residues by Biacore 
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adhesion assay, which is a label-free technique that allows to detect and monitor the 
interaction of bacterial surface protein and target ligands in real time. Since a 
relationship between acidic mucin and microflora was proved, the results in this 
chapter may be helpful to understand the adhesion strategies of bowel bacteria.  
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Materials and Methods 
1. Preparation of bacterial cells and cell surface proteins 
Lactobacillus strain OLL2785, L. gasseri OLL2877 and B. bifidum MCC1092 
were provided from the culture collection of Meiji Co., Ltd. and Morinaga Milk 
Industry Co., Ltd. as mentioned before. The bacterial cells of the three strains were 
shown to bind to acidic residues in sHCM (67). The lactobacilli and bifidobacteria 
strains were propagated twice before the experiments at 37 °C for 16 h with a 2% (v/v) 
and 10% (v/v) inoculum, respectively. After incubation, bacterial cells were collected 
from the culture medium using centrifugation (8500 × g, 4 °C, 10 min) and washed 
three times with PBS (pH 7.4). The PBS wash fraction was collected and retained. 
After removing the media components, the bacterial cells were lyophilized as 
untreated cells. To prepare cell surface proteins, the bacterial cells were incubated in 2 
M GHCl at 37 °C for 2 h. After centrifugation (8500 × g, 4 °C, 30 min), the pellet 
(GHCl-treated bacterial cells) and the supernatant (GHCl-extracted fraction) were 
dialyzed against distilled water at 4 °C for 48 h and then lyophilized. The PBS wash 
fraction was also dialyzed and lyophilized. 
Before using the Biacore assay, the bacterial cells and cell surface proteins were 
suspended in HBS-EP buffer (GE Healthcare Bio-Sciences K.K., Tokyo, Japan) as the 
analyte (3 mg/mL) in the Biacore assay. 
 
2. Identification of Lactobacillus strain OLL2785 by 16S rRNA gene sequence 
Lactobacillus strain OLL2785 was grown in MRS broth (Difco Laboratories); and 
propagated once at 37 °C for 16 h with a 1% (v/v) inoculum. After that, OLL2785 
`strain was cultured in MRS agar (1.5 % (w/v) agar in MRS broth) at 37 °C for 84 h.	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Three bacterial colonies on the agar were selected for direct polymerase chain 
reaction (PCR). The universal primers 35F and 1492R were used (68). Amplification 
was performed in a 20 µL reaction mixture containing 10 µL TAKARA Ex Taq 
(Takara Shuzo), 200 µL 10× Ex Taq buffer, 160 µL dNTP mixture (2.5 mM each), 
each promer (10 pmol), and bacterial cells. The samples were amplified using a 
C1000™ Thermal Cycles (Bio-Rad, CA, USA) and the following: 95 °C for 3 min; 
30 cycles of 95 °C for 30 s, 50 °C for 30s, and 72 °C for 90 s; and finally 72 °C for 10 
min (Table 3-1). After electrophoresis and purification with ExoSAP-IT (GE 
Healthcare), approximately 500 base pair (bp) of the 5’ end of the 16S rRNA gene 
containing hypervariable regions V1 to V3 was sequenced using the 35F primer, a 
Big Dye Terminator Cycle Sequencing Kit (Applied Biosystems, CA, USA) and an 
ABI PRISM 3130x1 Genetic Analyzer (Applied Biosystems). Sequences were 
compared with similar sequences to the reference organisms using EzTaxon server 
2.1 (http://147.47.212.35:8080/) or a BLAST search (http://blast.ncbi.nlm.nih.gov/). 
 
3. The growth curve of OLL2785, OLL2877, and MCC1092 strains 
To determine the growth curve, lactobacilli and bifidobacteria were propagated in 
the conditions mentioned before, and were grown in 5 mL broth with 2% (v/v) and 
10% (v/v) inoculum, respectively. Growth curve and bacterial concentrations were 
determined by measuring optical density (OD) at 560 nm each 120 min. 
 
4. The ligands using in Biacore assay 
All Biacore experiments were performed using a Biacore 1000 (GE Healthcare 
Bio-Sciences K.K.) at 25 °C in HBS-EP buffer. sHCM and biotinylated probes were 
used as ligands immobilized on CM5 and SA sensor chips, respectively.  
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4-1. Soluble human colonic mucin (sHCM) 
Purification and immobilization of sHCM was performed as described in chapter 2 
(67). Briefly, crude mucus was scraped from the normal intestinal tissues of colorectal 
cancer patients. After removing lipids by chloroform: methanol (2:1, v/v) and diethyl 
ether, the lipid-free mucus was digested with Proteinase K (TaKaRa Biotechnology), 
and purified by gel filtration chromatography with a Toyopearl HW-65F column (90 
× 2.6 cm; Tosoh). Fractions containing high concentrations of sugars and peptides 
were collected as the ligand for the Biacore analysis. The immobilization of sHCM on 
a CM5 sensor chip (GE Healthcare Bio-Sciences K.K.) was an amine coupling 
reaction following the manufacturer’s instructions. sHCM was dissolved at 10 mg/mL 
in 10 mM sodium acetate buffer (pH 4.0) and immobilized using the reaction between 
NHS-esters and radicals of primary amino groups in sHCM. A blank flow cell on 
CM5 chip activated by an EDC/NHS mixture and deactivated by ethanolamine 
hydrochloride was used as control flow cell. This study was approved by the ethics 
committee of Tohoku University Graduate School of Medicine. 
 
4-2. Biotinylated probes 
The following biotinylated probes were used as ligands in this study: α-Neu5Ac-
polyacrylamide (PAA)-biotin (Neu5Ac-PB), β-D-Galactose-PAA-biotin (Gal-PB), β-
D-Gal-3-sulfate-PAA-biotin (Gal-3-S-PB), β-GlcNAc-PAA-biotin (GlcNAc-PB), and 
β-D-GlcNAc-6-sulfate-PAA-biotin (GlcNAc-6-S-PB) (GlycoTech, MD, USA) (Fig. 
3-1). The polymeric probe was immobilized using biotin-avidin binding reaction to 
the sensor chip SA. The SA chip was first cleaned with three 1-min injections of 10 µl 
of a solution of 1M NaCl in 50 mM NaOH before the immobilization procedure. 
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When the sensorgram reached a stable baseline, the biotinylated probe, diluted in 
HBS-EP buffer to 40 µg/mL, was injected for 10 min using a flow rate of 10 µL/min. 
After that, a 1-min injection of 10 µl of a solution of 1M NaCl in 50 mM NaOH was 
repeated to clear unbound probes. The sensor chip was equilibrated in HBS-EP buffer. 
 
5. The adhesion assay using Biacore 
Quantifying adhesion assay using the Biacore 1000 is based on the principle of 
surface plasmon resonance (53). After washing and lyophilization, bacterial cells and 
cell surface proteins as analytes were suspended at a concentration of 3 mg/mL in 
HBS-EP buffer. After injecting bacterial cells or cell surface proteins at a flow rate of 
3 µL/min for 5 min, the sensor chip was washed with HBS-EP buffer to remove 
unbound analyte; and regenerated eluting with 1 M GHCl solution at a flow rate of 3 
µL/min for 2 min. The resonance units (RU) were measured for 200 s after the 
cessation of sample addition. A response of 1 RU represents about 1 pg/mm2 protein 
adhering with increased concentration of analyte bound to the sensor chip surface. 
The overlaid sensorgrams were created using BIAevaluation software pachage 
(version 3.1). 
 
6. Statistical analysis 
All experiments were performed in triplicate and reported as the mean ± SD. For 
adhesion test of cell surface proteins using Biacore assay, statistical analysis of the 
data was performed using the Student’s t-test. For each statistic, significant 
differences were inferred whenever the p-value was <0.05. 
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Table 3-1. Primers used for sequence of 16S rRNA genes  
and PCR conditions 
 
Primer Sequence (5’-3’) 
35F CCTGGCTCAGGATGAACG 
1492R GGTTACCTTGTTACGACTT 
 
Component of pre-mixture Volume (µL) 
TaKaRa Ex Taq™ HS polymerase (5 units/µL)  0.1 
10× Ex Taq buffer 2.0 
dNTP mixture 1.6 
10 µM 35F primer 0.2 
10 µM 1492R primer 0.2 
Sterilized distilled water up to 20.0 
 
PCR cycle 
95 °C 180 sec 
95 °C 30 sec 
50 °C 30 sec 
72 °C 90 sec 
72 °C 600 sec 
  4 °C ∞ 
 
× 30 cycles 
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Figure 3-1. The structure of biotinylated probes used in this study. PAA: 
polyacrylamide, Gal: galactose, GlcNAc: N-acetylglucosamine, Neu5Ac: 
N-acetylneuraminic acid, S:sulfate. 
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Results 
1. Identification of Lactobacillus strain OLL2785 by 16S rRNA gene sequence 
Since the bacterial species of OLL2785 strain was still unknown, the species 
identification by 16S rRNA gene sequence was performed. After amplified by the 
universal primers 35F and 1492R, approximately 500 base pair (bp) of the 5’ end of 
the 16S rRNA gene containing hypervariable regions V1 to V3 was sequenced (Fig. 
3-2). By comparing with the reference organisms, OLL2785 showed 100% similarity 
to L. fornicalis, 99.281% to L. psittaci and L. jensenii (Table 3-2). Thus, OLL2785 
was identified as L. fornicalis in species level identification. 
 
2. The growth curve of L. fornicalis OLL2785, L. gasseri OLL2877, and B. 
bifidum MCC1092 
The growth curve of the three strains was measured after twice propagation. Two 
lactobacilli strains showed similar growth curve. The log phase started in 2 h and the 
stationary phase began in 8 to 10 h in L. fornicalis OLL2785. In L. gasseri OLL2877, 
the lag phase was not obvious; and the stationary phase started in 10 h. After 18 h 
incubation, the bacterial cell concentration of L. fornicalis OLL2785 and L. gasseri 
OLL2877, observed by optical microscope, came to 1.5 × 1010 and 4.0 × 109 cells/mL. 
The growth curve of B. bifidum MCC1092 was different from the two lactobacilli. 
The lag phase ended in 4 h. The log phase was from 4 to 12 h. Until 20 h, the bacterial 
cell concentration came to 4.0 × 109 cells/mL (Fig. 3-3). 
 
3. Analysis of adhesive properties of bacterial surface proteins to acidic residues 
using the Biacore assay 
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In chapter 2, a new screening method was developed to measure the binding 
between bacteria and acidic residues in sHCMs using the Biacore binding assay. Two 
lactobacilli strains and one bifidobacteria strain were selected with strong adhesion to 
acidic residues of sHCM. Here, I further confirmed the binding between the cell 
surface proteins of the two lactobacilli and sHCM. To quantify the binding between 
the cell surface proteins and the specific structure of acidic residues, the biotinylated 
probes containing the structure of acidic residues in HCM were used as ligands in 
Biacore assay in this study. 
 
3-1. The binding between cell surface proteins and sHCM 
To confirm whether the adhesin-like components were removed by GHCl 
extraction, the adhesion value of the GHCl-treated and untreated bacteria were 
compared in the Biacore adhesion assay. Untreated OLL2877 cells adhered to sHCM 
at 323.1 ± 58.9 RU, whereas a significant reduction was shown with GHCl-treated 
cells to sHCM at 1.8 ± 0.5 RU (p < 0.01). The unsmooth curve of OLL2877 was due 
to the aggregation property (Fig. 3-4). The OLL2785 and MCC1092 strains also 
showed a significant reduction of adhesion value in GHCl-treated cells (data not 
shown), suggesting the adhesin-like components were extracted by GHCl solution. 
Here, the PBS wash fractions and the GHCl-extracted fractions from the strains 
were tested for adhesion to sHCM and control flow cell. Most of the fractions adhered 
to sHCM significantly when compared to control (p < 0.05). In both OLL2785 and 
OLL2877 strains, the adhesion values of GHCl-extracted fractions were significantly 
higher than PBS wash fractions (p < 0.01), and the 2M GHCl-extracted fractions 
showed the highest binding to sHCM among the three kinds of fractions (23.1 ± 5.3 
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RU and 1972.3 ± 185.5 RU, respectively). However, in MCC1092 strain, the binding 
of PBS wash fraction was higher than the GHCl fractions (Fig. 3-5). 
 
3-2. The binding between cell surface proteins and acidic residues 
After proving the binding ability of cell surface proteins to sHCM, the adhesion 
between the bacterial cell surface protein and the probes with acidic residues was 
further determined. Here, SA sensor chip immobilized with the biotinylated probes 
was used, whereas CM5 sensor chip was used for immobilization of sHCM. The 
immobilization amounts of Gal-3-S-PB, GlcNAc-6-S-PB and Neu5Ac-PB were 806.5, 
785.1, and 164.0 RU, respectively (Table 3-3). From the sensorgrams of 
immobilization, the association rate of GlcNAc-6-S-PB was higher than Gal-3-S-PB. 
Neu5Ac-PB was the lowest one (Fig. 3-6).  
The adhesion values of cell surface proteins to acidic residues were measured. In 
both OLL2785 and OLL2877 strains, the adhesion values of 2M GHCl-extracted 
fractions were significantly higher than PBS wash fractions (p < 0.05). The 2M GHCl 
fractions of OLL2785 and OLL2877 showed highest binding to Gal-3-S (73.0 ± 6.7 
RU and 792.1 ± 94.5 RU, respectively). However, in MCC1092, there was no 
significant difference (Fig. 3-7). Among the three strains as analyte, OLL2877 
showed the highest binding to the three acidic probes (Fig. 3-8).  
 
3-3. The binding between cell surface proteins and monosaccharides 
The biotinylated probes without acidic residues were used as negative control, 
which were Gal-PB and GlcNAc-PB. Compared to the corresponding acidic probes, 
the decrease of immobilized amount in Gal-PB and GlcNAc-PB was due to lower 
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mass (Table 3-4). The immobilization of Gal-PB, GlcNAc-6-S-PB, and GlcNAc-PB 
was completed in 50 s, which of Gal-3-S was completed in 400s (Fig. 3-9). 
The adhesion values of 2M GHCl-extracted fractions to the biotinylated probes 
with/without acidic residues were measured. In OLL2785 and OLL2877 strains, the 
adhesion values of the 2M GHCl fractions to the acidic probes (Gal-3-S-PB and 
GlcNAc-6-S-PB) were significantly higher than to the probes without acidic residues 
(Gal-PB and GlcNAc-PB). The adhesion values of 2M GHCl fraction from OLL2877 
to Gal-3-S (841.3 ± 12.9 RU) and GlcNAc-6-S (646.5 ± 1.9 RU) were significantly 
higher when compared to Gal (363.4 ± 0.8 RU) and GlcNAc (429.4 ± 0.9 RU) (p < 
0.001). Same as the results of the adherence to sHCM, OLL2877 showed the highest 
adherence to the acidic probes among the three strains. However, there was no 
significant difference in MCC1092 (Fig. 3-10). Due to the insolubility of 2M GHCl 
fraction from MCC1092, the unsmooth curves were observed in the Biacore 
sensorgrams.  The 2M GHCl fraction from OLL2785 showed higher association rate 
and dissociation rate than which from OLL2877, but the binding values were higher 
in OLL2877 (Fig. 3-11).  
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TGCAGTCGAGCGAGCTTGCCTATTGAAATTCTTCGGAATGGACATAGATA
CAAGCTAGCGGCGGATGGGTGAGTAACGCGTGGGTAACCTGCCCTTAA
GTCTGGGATACCATTTGGAAACAGATGCTAATACCGGATAAAAGCTACTT
TCGCATGAAAGAAGTTTAAAAGGCGGCGTAAGCTGTCGCTAAAGGATGG
ACCTGCGATGCATTAGCTAGTTGGTAAGGTAACGGCTTACCAAGGCGAT
GATGCATAGCCGAGTTGAGAGACTGATCGGCCACATTGGGACTGAGACA
CGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCACAATGG
ACGCAAGTCTGATGGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGAT
CGTAAAGCTCTGTTGTTGGTGAAGAAGGATAGAGGTAGTAACTGGCCTT
TATTTGACGGTAATCAACCAGAAAGTCACGGCTAACTACGTGCCAGCAG
CCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGATTTATTGGGCGTAA
AGCGAGCGCAGGCGGATTGATAAGTCTGATGTGAAAGCCTTCGGCTCAA
CCGAAGAACTGCATCAGAAACTGTCAATCTTGAGTGCAGAAGAGGAGAG
TGGAACTCCATGTGTAGCGGTGGAATGCGTAGATATATGGAAGAACACC
AGTGGCGAA 
 
Figure 3-2. DNA sequences from the 5’ end of the 16S rRNA gene from 
Lactobacillus strain OLL2785 (695 bp). 
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Table 3-2. 16S rDNA-based identification of OLL2785 strain by Eztaxon. 
The data are representative of three independent experiments. 
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Figure 3-3. Growth curves of L. fornicalis OLL2785, L. gasseri OLL2877, 
and B. bifidum MCC1092 with 2%, 2%, and 10% (v/v) inoculum, 
respectively. The measurement of OD were performed each 120 min. The 
data represent means (n = 3). 
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Figure 3-4. Representative overlaid sensorgrams illustrating adhesion 
assay of untreated (panel a) and GHCl-extracted bacterial cells (panel b) 
from L. gasseri OLL2877 to sHCM. 
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Figure 3-5. Binding abilities of the bacterial cell surface proteins to 
sHCM using the Biacore assay. ‘PBS’ and  ‘GHCl’ are PBS wash fraction 
and the GHCl-treated fraction of each strain, respectively. Columns 
represent the mean ± SD (n = 3).*p < 0.05; **p < 0.01; ***p < 0.001. 
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Table 3-3. Probes used for determining the binding abilities of the 
surface proteins of lactobacilli and bifidobacteria to the biotinylated 
probes containing acidic residues, and their immobilized amount to 
sensor chip SA. 
 
 
FC1: β-D-Gal-3-sulfate-PAA-biotin 
FC2: β-D-GlcNAc-6-sulfate-PAA-biotin 
FC3: α-Neu5Ac-PAA-biotin 
FC4: Blank 
 
SA sensor chip FC1 FC2 FC3 FC4 
 Gal-3-sulfate 
GlcNAc-6-
sulfate Neu5Ac Blank 
Immobilized amount 
(RU) 806.5 785.1 164.0 0 
 
 
Sulfate probe 
 
	  
Neu5Ac probe 
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Figure 3-6. Biacore sensorgrams of immobilization of (a) Gal-3-S-PB, (b) 
GlcNAc-6-S-PB, and (c) Neu5Ac-PB on the sensor chip SA. 
(a) 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
(c) 
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Figure 3-7. Binding abilities of the PBS wash fraction and the 2M GHCl 
extract fraction of the selected strains to the biotinylated probes 
containing acidic residues using Biacore analysis. Columns represent 
the mean ± SD (n = 3). *p < 0.05; **p < 0.01. 
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Figure 3-8. Representative overlaid sensorgrams illustrating adhesion 
assay of 2M GHCl extract fraction of the selected strains to (a) Gal-3-S-
PB, (b) GlcNAc-6-S-PB, and (c) Neu5Ac. 
(a) 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
(c) 
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Table 3-4. Probes used for determining the binding abilities of the 
surface proteins of lactobacilli and bifidobacteria to the biotinylated 
probes containing sulfate residues and the control probes. The 
immobilized amounts to sensor chip SA also show below. 
  
FC1: β-D-Gal-3-sulfate-PAA-biotin 
FC2: β-D-Gal-PAA-biotin 
FC3: β-D-GlcNAc-6-sulfate-PAA-biotin 
FC4: β-D-GlcNAc-PAA-biotin 
 
SA sensor chip FC1 FC2 FC3 FC4 
 Gal-3-sulfate Gal GlcNAc-6-sulfate GlcNAc 
Immobilized amount 
(RU) 914.8 857.6 986.1 937.2 
 
Gal-3-sulfate and 
Gal probe 
 GlcNAc-6-sulfate and 
GlcNAc probe 
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Figure 3-9. Biacore sensorgrams of immobilization of (a) Gal-3-PB, (b) 
Gal-PB, (c) GlcNAc-6-S-PB, and (d) GlcNAc-PB on the sensor chip SA. 
(a) 
 
 
 
 
 
(b) 
 
 
 
 
 
 
(c) 
 
 
 
 
 
 
(d) 
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Figure 3-10. Binding abilities of the 2M GHCl extract fractions of the 
selected strains to the biotinylated probes containing sulfate residue 
and the control probes using Biacore analysis. Columns represent the 
mean ± SD (n = 3). **p < 0.01; ***p < 0.001. 
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Figure 3-11. Representative overlaid sensorgrams illustrating adhesion 
assay of 2M GHCl extract fraction of (a) L. fornicalis OLL2785, (b) L. 
gasseri OLL2877, and (c) B. bifidum MCC1092 to the biotinylated probes. 
(a) 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
(c) 
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Discussion 
Adhesive characteristics of bacteria vary among strains and species (69). Though 
specific mechanisms are still unclear, there are some interactions proved to be 
involved in intestinal mucus adhesion. The most studied one is carbohydrate-protein 
interaction. The cell surface protein produced by bacteria, such as mucus-binding 
protein (MUB) by L. reuteri (70), pili subunit from L. rhamnosus GG (71), and 
elongation factor Tu (EF-Tu) (72), plays an important role in the adhesion to mucin-
bound oligosaccharides. Since Neu5Ac and sulfate residues are predominantly linked 
to HCM, a new screening method to evaluate the binding of probiotics to acidic 
residues was constructed in chapter 2. Following the results, three high-adhesive 
probiotics binding to acidic residues were selected for further studies. In this chapter, 
to clarify their adhesive properties, I tried to prepare cell surface proteins from the 
selected probiotics, and measured their binding to the biotinylated probes 
with/without acidic residues of HCM using the Biacore adhesion assay. 
The species level identification of Lactobacillus strain OLL2785 and the growth 
curves of three probiotics were determined at first. OLL2785 was identified as L. 
fornicalis using 16S rRNA gene sequencing. L. fornicalis was isolated from the 
posterior fornix fluid of the human vagina, which is a non-motile, non-sporulating, 
catalase-negative and oxidase-negative bacterium with optimum temperature on 
growth between 35 and 37 °C. Also, it is facultatively anaerobic and obligately 
homofermentative with no gas production from glucose (73). In this study, OLL2785 
was isolated from human feces. Results showed the stationary phase of L. fornicalis 
OLL2785 began in 8 to 10 h after 2% inoculation, which was similar to that of L. 
gasseri OLL2877 (10 h) but different from that of B. bifidum MCC1092 (12 h). Thus, 
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the preparation of cell surface protein was performed after 16 h incubation to collect 
bacterial cells in the stationary phase. 
Here, the binding between bacteria surface proteins and sHCM were measured 
using Biacore. By comparing the binding of untreated and 2M GHCl-treated cells to 
sHCM, it was determined that the adhesin-like components on cell surface were 
extracted by 2M GHCl. For OLL2785 and OLL2877, the adhesion values of 2M 
GHCl-extracted fractions were significantly higher than PBS wash fractions (p < 
0.05), suggesting the adhesin-like components may exist in 2M GHCl-extracted 
fractions. For B. bifidum MCC1092, the adhesion value of PBS wash fraction was 
higher than GHCl fraction. It suggests that the adhesin-like components on cell 
surface of MCC1092 were washed off in the step of three-time washing by PBS. 
Compared to MCC1092, the adhesion values of PBS wash fraction from OLL2785 
and OLL2877 were extremely low (< 20 RU). However, when the binding of surface 
protein to acidic residues was measured, I found the adhesion value of PBS wash 
fraction was lower than 2M GHCl-extracted fraction from MCC1092, indicating that 
the adhesin-like components in PBS wash fraction bound to parts of sHCM besides 
acidic residues. On the other hand, the 2M GHCl fractions from OLL2785 and 
OLL2877 showed significantly higher binding than PBS wash fraction in both 
adhesion assay to sHCM and acidic residues (p < 0.05). Thus, the binding to acidic 
residues contributed to the higher binding of both lactobacilli to sHCM. 
Since the binding values of the 2M GHCl fractions from OLL2785 and OLL2877 
strains to sulfate probes were significantly higher than those to Neu5Ac probe (p < 
0.05), the binding to the biotinylated probes with/without sulfate residue was also 
determined. By comparing the binding to Gal-3-S/GlcNAc-6-S and Gal/GlcNAc, the 
effect of sulfate residue on adhesion could be clarified. In OLL2785 and OLL2877, 
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the binding to Gal-3-S was significantly higher than that to GlcNAc-6-S, but the 
adhesion values to Gal were lower than that to GlcNAc. It suggests that the higher 
binding to Gal-3-S than GlcNAc-6-S was not contributed by the different 
monosaccharide liked to sulfate. The whole structure of Gal-3-S may be recognized 
by adhesin-like components from OLL2785 and OLL2877, because Gal-3-S is the 
most predominant structure in human colonic acidomucin (29). 
Few studies concern the adhesins from probiotics binding to sulfomucin, but some 
adhesins from pathogens were reported to show specific binding to sulfate residue 
expressed in mucin. The piliated strain of Pseudomonas aeruginosa bound more 
strongly to highly sulfated salivary mucin from cystic fibrosis than the nonpiliated 
strain (60), and P. aeruginosa flagellin were found to be an adhesin for MUC1 mucin 
(74). H. pylori was reported to adhere to SO3-3-Gal in salivary mucin (75), and a 
neutrophil-activating protein expressed on its surface was identified to bind 
specifically to sulfated oligosaccharides in salivary mucin (44). Furthermore, a report 
indicated that the binding of H. pylori urease to gastric epithelial cells was decreased 
after the addition of sulfated polysaccharides in vitro, indicating the urease had 
specific binding to sulfate derivatives (76). 
Moreover, studies also indicated sialic acid may be a potential binding site for 
bacteria. H. pylori is well known to adhere sialyl-Lewis x antigens on gastric 
epithelium by sialic acid-binding adhesin (SabA) (57). The K88 fimbrial adhesin 
expressed on the surface of enterotoxigenic Escherichia coli (ETEC) showed binding 
to sialoglycoproteins from porcine intestine (58). Also, M protein from Streptococcus 
pyogenes (45) and Hsa protein (203 kDa) from S. gordonii (77) were also reported to 
bind to the sialic acid moieties on mucin. Although the adhesion values to Neu5Ac 
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were lower than sulfate residue in this study, the existence of Neu5Ac-binding 
adhesin from probiotics is still possible. 
In the next chapter, the adhesin-like components were detected on the bacterial cell 
body in situ, and identified using receptor overlay and N-terminal amino acid 
sequencing analyses. 
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CHAPTER 4 
Detection and identification of adhesin-like 
components from probiotics with specific affinity to 
acidic residues in human colonic mucin 
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Introduction 
In chapter 3, the cell surface proteins from L. gasseri OLL2877 showed highest 
adhesion values to sHCM and the biotinylated probes containing acidic residues, at 
least 10 times higher than that from L. fornicalis OLL2785 and B. bifidum MCC1092. 
Among the probes containing different acidic residue, the cell surface proteins from L. 
gasseri OLL2877 and L. fornicalis OLL2785 showed highest binding to Gal-3-S, 
which is the most predominant structure in human colonic acidomucin (29). However, 
the specific molecular from these surface proteins recognized sulfate residue on 
mucin oligosaccharides was still unknown. 
The classical theories of adhesion of bacteria suggest two to five stages in the 
process, including passive van der Wall’s attractive forces, electrostatic interactions, 
hydrophobic, steric forces, lipoteichoic acid, and frequently active adhesion through 
the production of specific structures by the bacteria, such as external appendages 
covered by lectins and/or extracellular polymers (polysaccharides) (78). An adhesion-
promoting protein (29 kDa) is present on the surface of L. fermentum 104R and 
involved in the binding to mucus from the small intestine and stomach of piglets (79). 
From L. johnsonii La1, lipoteichoic acid isolated from bacterial cell wall is 
responsible for the concentration-dependent inhibition of La1 adhesion to Caco-2 
cells (80). Lectin-like protein structures were found on the cell surfaces of L. animalis 
and L. fermentum (81), and the aggregation-promoting factor protein located on the 
cell surface were identified and sequenced from L. johnsonii and L. gasseri (82), 
which may be involved in the interactions between the lactobacilli and intestinal 
epithelium. However, very few studies concentrate on the adhesin-like component 
involved in the adhesion to acidic residues of intestinal mucin. 
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Therefore, in this chapter, I tried to detect the adhesin-like component on the 
bacterial cell body in situ, and identified the specific molecules binding to Gal-3-S 
probe using receptor overlay and N-terminal amino acid analyses. 
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Materials and Methods 
1. Bacterial strains and preparation of cell-surface proteins 
L. fornicalis OLL2785, L. gasseri OLL2877 and B. bifidum MCC1092 were 
propagated twice before the cultivation in 500 mL broth at 37 °C for 16 h with 2%, 
2%, and 10% (v/v) inoculum as mentioned before. After incubation, bacterial cells 
were collected from the culture medium using centrifugation (8500 × g, 4 °C, 10 min) 
and washed three times with PBS (pH 7.4). To prepare cell surface proteins, the 
bacterial cells were incubated in 2 M GHCl at 37 °C for 2 h. After centrifugation 
(8500 × g, 4 °C, 30 min), the supernatant (2M GHCl-extracted fraction) were dialyzed 
against distilled water at 4 °C for 48 h and then lyophilized. The samples were stored 
at -20 °C until use. 
 
2. In situ detection of Gal-3-S-binding components on bacterial surface 
2-1. Preparation of bacterial smear on slide glass 
An indirect fluorescent labeling of cell surface components of bacteria cells was 
preformed using the binding of biotinylated probes and fluorochrome-streptavidin 
conjugate (83) (Fig. 4-1). After incubation in 30 mL broth, the selected strains were 
collected from the culture medium using centrifuging 10 min at 3500 × g, 4 °C. After 
removing supernatant, the bacterial cells were washed two times with 10 mL PBS. 
The pellet was resuspended in PBS to a final cell concentration of 5×107 cells/mL 
using a bacteria counter (AS ONE corporation, Osaka, Japan). To prepare the smears 
for the test, 10 µL bacterial suspension was transferred to the center of a clean slide 
(Matsunami Glass Ind., Ltd., Osaka, Japan), and spread out to achieve a thin layer 
using a loop. After air dry, the slide was submerged in a Coplin jar containing 95% 
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ethanol (Wako Pure Chemical Industries) for 1 min at room temperature, and excess 
ethanol was drained off. Finally, the slide was dipped into PBS in a Coplin jar, and 
heated to 55 °C for 10 min. Slides can be stored up to 1 year at -70 °C at this step. 
 
2-2. Fluorescent staining of bacteria 
The Gal-3-S-PB probe was diluted into 50 µg/mL. Smears were covered with 200 
µL diluted probe, placed in a petri dish with moistened kimwipes, and incubated at 
room temperature overnight. The slides were rinsed in 20 mL PBS to remove any 
debris and incubated in a petri dish filled with 20 mL PBS for 30 min at room 
temperature. Then, the smears were covered with 200 µL Alexa Fluor 488 
streptavidin conjugate (Invitrogen, CA, USA) diluted into 10 µg/mL, and incubated 
for 1 h at room temperature in dark. From this step, the slides were protected from 
light carefully. The slides were rinsed and incubated in PBS again for 30 min at room 
temperature. After that, the smears were covered with 200 µL 4’, 6-diamidino-2-
phenylindole (DAPI, Dojindo Molecular Technologies, Kumamoto, Japan) diluted 
into 1 µg/mL, and incubated for 5-10 min at room temperature. After rinsed and 
incubated in PBS again for 30 min at room temperature, the slides were rinsed by 
distilled water and allowed to air dry. To preserve the smears, 20 µL mounting 
medium (Thermo) and an 18 mm × 18 mm coverslip (Matsunami Glass Ind., Ltd.) 
were added to the slides. After the mounting medium was completely dry, the slides 
were sealed by applying clear fingernail polish around the sides of the coverslip. The 
slides were stored in the dark at room temperature. Negative control was similarly 
operated by replacing Gal-3-S-PB probe with PBS. 
 
2-3. Observation and quantification of fluorescent-labeled bacteria 
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The slides were observed using a laser scanning microscope LSM700 (Carl Zeiss 
Microscopy, Cambridge, UK). Imaging data were analyzed using ImageJ software 
(NIH freeware, available at http://rsb.info.nih.gov/ij/download.html) to quantify 
fluorescence from all experiments. The area stained by DAPI (blue) and Alexa Fluor 
488 (green) in images were selected by using the “Threshold” function, and counted 
by using “Analyze Particles” function. Blue fluorescence readings (DAPI) were used 
as a control to count the bacteria number in the microscope field of view (160 µm × 
160 µm). The readings of the green fluorescent images (Alexa Fluor 488) were used 
to quantify the cell surface components binding to Gal-3-S-PB probe by measuring 
“Total Area” in the field of view. Using the equation below, the intensity of Gal-3-S-
binding components per bacterial cell was calculated. 
y (µm2/cell)  = !"#$%  !"#$!"#$%&'(  !"#$%& 
3. SDS-PAGE analysis 
Cell surface proteins of each bacterial strain were analyzed using sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis according to the 
method of Larmmli (84). The polyacrylamide slab gel was prepared using a 
discontinuous buffer system with a 4.5% stacking gel and a 12.5% separation gel (10 
× 12 cm). Molecular marker proteins and samples were dissolved in SDS buffer (62.5 
mM Tris, 2% SDS, β-mercaptoethanol, 0.001% bromophenol blue and 10% glycerol, 
pH 6.8), following by heating at 99 °C for 10 min. SDS-PAGE was performed using 
an X Cell SureLock™ Electrophoresis Cell (Invitrogen) at a constant voltage of 125 
V with a Power PAC 3000 (Bio-Rad) in running buffer containing 0.025 M Tris, 0.2 
M glycine and 0.1% SDS. Proteins were visualized with Coomassie Brilliant Blue 
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(CBB) (Rapid CBB; Kanto Chemical Co., Inc., Tokyo, Japan). SeeBlue® Plus2 pre-
stained standard (Invitrogen) was used as molecular weight marker. 
 
4. Receptor overlay analysis 
A modified receptor overlay (RO) protein binding assay adapted from (85) was 
used (Fig. 4-2). Cell surface proteins were subjected to SDS-PAGE and transferred to 
a polyvinylidene difluoride (PVDF) membrane. Blots were blocked in SuperBlock 
Blocking buffer (Thermo Scientific, CA, USA) for 30 min, washed with Tris-buffered 
saline buffer (20 mM Tris, 150 mM NaCl, pH 8.2) containing 0.05% Tween 20 (TBS-
T), and incubated overnight with the biotinylated probes containing acidic residues 
(Neu5Ac-PB, Gal-3-S-PB, and GlcNAc-6-S-PB) at 5 µg/mL in TBS-T buffer at room 
temperature. A negative control was similarly operated that the blots were incubated 
with TBS-T buffer overnight. The blots were then washed and further incubated for 
30 min with ExtraAvidin-Alkaline Phosphatase (Sigma-Aldrich) at a 1:30,000 
dilution. The blots were again washed, and probe-binding proteins were visualized 
with ECL reagents (Invitrogen). 
 
5. N-terminal amino acid sequence analysis 
After SDS-PAGE analysis and transferred to a PVDF membrane, the proteins were 
stained with CBB, excised from PVDF membrane, and destained with 100% 
methanol. The N-terminal amino acid sequence was determined using an ABI Procise 
491HT protein sequencer (Applied Biosystems), and BLASTP search was performed 
(http://blast.ncbi.nlm.nih.gov/).  
 
6. Statistical analysis 
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All experiments were performed in triplicate and reported as the mean ± SD. For 
the fluorescent detection of Gal-3-S-binding components on bacterial surface, 
statistical analysis of the data was performed using the Student’s t-test. For each 
statistic, significant differences were inferred whenever the p-value was <0.05. 
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Figure 4-1. The illustration of fluorescent staining of bacteria using Gal-
3-S-PB probe. 
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Figure 4-2. The illustration of receptor overlay analysis using 
biotinylated probes with acidic residues. 
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Results 
1. In situ Detection of bacterial surface proteins with specific affinity to Gal-3-S 
using indirect fluorescent labeling 
The smears were fixed on slide glasses by 95% ethanol. Using optical microscope, 
the microscopic characteristics of lactobacilli and bifidobacteria were observed (Fig. 
4-3). Since the Alexa Fluor 488 signals were very few in negative control, unspecific 
binding from streptavidin was excluded (Fig. 4-4). Using laser scanning microscope, 
the Gal-3-S-binding components were observed by fluorescence signals (Fig. 4-5). 
Under higher magnification, some bacterial cells of L. fornicalis OLL2785 were 
stained with Gal-3-S probe, suggesting the Gal-3-S-binding components were 
contained on the surface of bacterial cell body. For B. bifidum MCC1092, some short 
cells were stained. However, under flurorescence microscope, most of the Gal-3-S-
binding signals were around bacterial cell body of L. gasseri OLL2877 (Fig. 4-6).  
By analyzing the fluorescence images, the Alexa Fluor 488 signals were quantified 
and normalized by counting the number of particles stained by DAPI. The fluorescent 
area per cell of L. gasseri OLL2877 (0.62 ± 0.20 µm2/cell) was significantly higher 
than which of L. fornicalis OLL2785  (0.26 ± 0.15 µm2/cell) and B. bifidum 
MCC1092 (0.18 ± 0.19 µm2/cell) (p < 0.01). There was no significant difference 
between L. fornicalis OLL2785 and B. bifidum MCC1092 (Fig. 4-7). 
 
2. Detection of cell surface components from the probiotics with specific binding 
activity to acidic residues using receptor overlay analysis 
Using receptor overlay analysis with different biotinylated probes, the molecule 
with specific binding to different probes could be detected. Multiple bands were 
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observed in the 2M GHCl-extracted fractions of the strains after Coomassie Brilliant 
Blue staining. The molecular weight of the components from L. fornicalis OLL2785 
detected by acidic probes was mostly under 36 kDa. There were five bands detected 
by sulfate probes (Fig. 4-8). The components from L. gasseri OLL2877 detected 
showed a wide-range molecular weight from 64 to 8 kDa. There were eight bands 
judged as positive detection by sulfate probes (Fig. 4-9). Finally, there were seven 
molecules from B. bifidum MCC1092 judged as positive detection by sulfate probes, 
ranging from 36 to 8 kDa. The 64-kDa protein from B. bifidum MCC1092 was 
excluded from positive detection because of its strong binding to streptavidin (Fig. 4-
10).  
In the same bacterial strain, similar patterns were generally observed when the 
bands detected by Gal-3-S or GlcNAc-6-S probes. Also, the bands detected by 
Neu5Ac probe were different from sulfate probes, and fewer than that detected by 
sulfate probes. 
 
3. Identification of the new surface proteins from L. gasseri OLL2877 with 
specific binding activity to sulfate residue 
Since the surface proteins from OLL2877 showed the highest adherence to sHCM 
and acidic residues, the specific components from the 2M GHCl fraction of L. gasseri 
OLL2877 binding to acidic residues were further identified. Compared to the negative 
control that incubated with TBS-T buffer overnight, I focused on the five bands that 
showed specific binding to sulfate probes, which were at 64, 63, 34, 29, and 27 kDa 
(Fig. 4-9). 
The molecules with specific binding to sulfate probes were electrically transferred 
to a PVDF membrane, and the N-terminal amino acids were sequenced. Ten amino 
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acids residues from the N-terminal end of each molecule were identified (Fig. 4-11, 
representatively). Using the comparison of the sequences to the database, the 64-kDa 
and 63-kDa proteins showed 78% and 60% identity with identical protein pyruvate 
kinase, respectively. The 34-kDa and 29-kDa proteins showed 100% and 90% identity 
with 50S ribosomal protein L2 and L3, respectively. Finally, the 27-kDa protein 
showed 88% identity with 30S ribosomal protein S3 (Table 4-1). 
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Figure 4-3. Representative images of L. fornicalis OLL2785, L. gasseri 
OLL2877, and B. bifidum MCC1092 without staining observed by optical 
microscope. 
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Figure 4-4. Representative images of L. fornicalis OLL2785, L. gasseri 
OLL2877, and B. bifidum MCC1092 stained by Alexa Fluor 488 
streptavidin conjugate (green) and DAPI (blue) under a 400X view as 
negative control. 
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Figure 4-5. Representative images of L. fornicalis OLL2785, L. gasseri 
OLL2877, and B. bifidum MCC1092 stained by indirect fluorescent 
labeling (using Gal-3-S-PAA-biotin probe and Alexa Fluor 488 
streptavidin conjugate, green) and DAPI (blue) under a 400X view. 
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Figure 4-6. Representative images of L. fornicalis OLL2785, L. gasseri 
OLL2877, and B. bifidum MCC1092 stained by indirect fluorescent 
labeling (using Gal-3-S-PAA-biotin probe and Alexa Fluor 488 
streptavidin conjugate, green) and DAPI (blue) under high magnification. 
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Figure 4-7. Quantification of Alexa Fluor 488 fluorescence of the 
selected strains with a concentration of 5 × 107 cells/mL in 160 µm × 160 
µm fields of view. Columns represent means ± SD (n = 5). **p < 0.01; ***p 
< 0.001. 
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                                        M         1          2           3          4 
Figure 4-8. Detection of acidic residue-binding molecules in the 2M GHCl 
fraction of L. fornicalis OLL2785 (M: pre-stained molecular weight 
marker, lane 1: Coomassie Brilliant Blue-stained bands from the 2M 
GHCl fraction of L. fornicalis OLL2785, lane 2: receptor overlay assay 
using Neu5Ac probe, lane 3: receptor overlay assay using Gal-3-S probe, 
lane 4: receptor overlay assay using GlcNAc-6-S probe). The data are 
representative of three independent experiments. 
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Figure 4-9. Detection of acidic residue-binding molecules in the 2M GHCl 
fraction of L. gasseri OLL2877 (M: pre-stained molecular weight marker, 
lane 1: Coomassie Brilliant Blue-stained bands from the 2M GHCl 
fraction of L. gasseri OLL2877, lane 2: receptor overlay assay using 
Neu5Ac probe, lane 3: receptor overlay assay using Gal-3-S probe, lane 
4: receptor overlay assay using GlcNAc-6-S probe). The data are 
representative of three independent experiments. 
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Figure 4-10. Detection of acidic residue-binding molecules in the 2M 
GHCl fraction of B. bifidum MCC1092 (M: pre-stained molecular weight 
marker, lane 1: Coomassie Brilliant Blue-stained bands from the 2M 
GHCl fraction of B. bifidum MCC1092, lane 2: receptor overlay assay 
using Neu5Ac probe, lane 3: receptor overlay assay using Gal-3-S probe, 
lane 4: receptor overlay assay using GlcNAc-6-S probe). The data are 
representative of three independent experiments. 
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Figure 4-11. HPLC chromatogram of standard amino acid 
mV 
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Figure 4-11. HPLC chromatogram of N-terminal amino acid residue from 
the 34-kDa protein in the 2M GHCl-extracted fraction of L. gasseri 
OLL2877 (residues 1 and 2). 
mV 
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Figure 4-11. HPLC chromatogram of N-terminal amino acid residue from 
the 34-kDa protein in the 2M GHCl-extracted fraction of L. gasseri 
OLL2877 (residues 3 and 4). 
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Figure 4-11. HPLC chromatogram of N-terminal amino acid residue from 
the 34-kDa protein in the 2M GHCl-extracted fraction of L. gasseri 
OLL2877 (residues 5 and 6). 
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Figure 4-11. HPLC chromatogram of N-terminal amino acid residue from 
the 34-kDa protein in the 2M GHCl-extracted fraction of L. gasseri 
OLL2877 (residues 7 and 8). 
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Figure 4-11. HPLC chromatogram of N-terminal amino acid residue from 
the 34-kDa protein in the 2M GHCl-extracted fraction of L. gasseri 
OLL2877 (residues 9 and 10). 
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Table 4-1. Proteins identified on the surface of L. gasseri OLL2877 that 
adhered to sulfate residue 
 
Observed 
migration 
(kDa) 
Sequence Putative function 
Theoretical 
migration 
(kDa) 
Theoretical 
isoelectric 
point 
Homology 
(%) 
64 MKKTGIVMT pyruvate kinase 
(L. gasseri JV-V03) 
63.7 5.39 78 
63 MKQIKFVGTL pyruvate kinase 
(L. gasseri JV-V03) 
63.7 5.39 60 
34 AIIKYKPTTN 50S ribosomal protein L2 
(L. gasseri JV-V03) 
30.3 10.59 100 
29 TKGILGVKVG 50S ribosomal protein L3 
(L. gasseri JV-V03) 
22.6 10.02 90 
27 GQKINPEGKQ 30S ribosomal protein S3 
(L. gasseri ATCC 33323) 
24.8 10.25 88 
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Discussion 
Bacteria adhesion to mucosal epithelial cells in host is an initial and essential 
factor for colonization and propagation in the gastrointestinal (GI) tract. Until now, it 
is known that most commensal bacteria and pathogens express adhesive molecules on 
their cell surfaces that interact with extracellular matrix and some specific cell 
receptors in the GI tract of host. Gram-negative bacteria (e.g. Escherichia coli and 
Helicobacter pylori) produce flagella, conjugative pili, and other cell surface adhesive 
components (86), whereas gram-positive bacteria (e.g. Streptococcus, Staphylococcus, 
and Listeria) produce pili, surface protein, polysaccharides and lipids that may display 
adhesive functions (87). These surface components mediating adherence are called 
adhesins. In the previous chapters, the binding between cell surface proteins of three 
selected strains and acidic residues have been proved. Thus, I tried to detect the 
surface components of the selected strains by the binding to Gal-3-S probe in situ, and 
identify the adhesin-like molecules from OLL2877, which showed the highest 
adhesive abilities to sHCM and acidic residues, using receptor overlay and N-terminal 
amino acid sequencing analyses. 
The in situ detection of bacterial surface proteins showed similar results to the 
Biacore adhesion assay to sHCM and acidic residues that the binding of OLL2877 
was significantly higher than that of OLL2877 and MCC1092 strains (p < 0.05). 
However, the Gal-3-S-binding signals were not overlaid with the signals of bacterial 
nucleic acid. It may indicate the bond strength of the adhesin-like components was 
weaker in OLL2877 than that in OLL2785, thus they were released from OLL2877. 
Additionally, in the preliminary experiment, the incubation of Gal-3-S probe was 
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performed for 1 h, but the fluorescent signal was too weak to observe under laser 
microscope. Thus, the incubation time was increased to overnight.  
In receptor overlay analysis, results showed more binding-positive bands detected 
by sulfate probes than those by Neu5Ac probe. The similar patterns detected by 
sulfate probes in the same bacterial strain indicate that the adhesin-like molecules 
recognized by Gal-3-S and GlcNAc-6-S are almost identical. 
Since the adhesive ability of OLL2877 was extremely higher than the other two 
strains, the adhesin-like components detected by sulfate residues were identified. 
Using N-terminal amino acid sequence analysis, the five adhesin-like components 
from L. gasseri OLL2877 were identified as pyruvate kinase (PK), 50S ribosomal 
protein (Rp) L2, L3, and 30S Rp S3. PK is an enzyme catalyzing the last step of 
glycolysis, in which pyruvate and ATP are formed (88). As the results in this study, a 
report indicated similar results that PK from L. plantarum was found as cell wall-
associated protein (89). Bergonzelli et al. indicated that PK detected at the surface of 
L. johnsonii La1 showed strong binding to mucins obtained from HT29-MTX cells, 
but no stimulation of IL-8 secretion in epithelial cells and macrophage (90). Kelly et 
al. found that PK was recognized as cell-wall associated protein of L. salivarius subsp. 
salivarius UCC118 by two-dimensional electrophoresis, and thought to be associated 
with bacterial adhesion to animal and human intestinal tissue, and to both healthy and 
inflamed ulcerative colitis mucosa (91). Although there were few reports on bacterial 
PK and human intestine, PK from Streptococcus pneumoniae was reported as cell 
immunogenic component in human (92). 
Rps are found in every cell, which make up the ribosomal subunits involved in the 
process of protein translation. They also function in multiple extraribosomal activities, 
including DNA repair, cell death, inflammation, tumorigenesis, and transcriptional 
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regulation (93). In eukaryotes, they were reported to inhibit mRNA splicing (94), 
shorten its own mRNA (95), promote p53 translation (96), bind to NF-κB (97), and be 
involved in P. aeruginosa pathogenesis (98). Human Rp S3 is well known to have 
identical amino acid sequence as a multifunctional protein involved in bacterial 
infection (99). On the other hand, in prokaryotes, some of Rps were reported to inhibit 
translation of polycistronic mRNA and S10 operon (100), participate DNA repair 
(101), autogenously regulate translation (102, 103), and influence RNAse E (104).  
Here, Rp L2, L3, S3 were found expressing on the bacterial surface of L. gasseri 
OLL2877 by 2M GHCl extraction. A study showed that about one-third of the 
identified cell wall resident proteins from Bacillus subtilis were Rps, whereas thirteen 
identified Rps, including L2, L3, and S3, were found after the bacterial cells treated 
with trypsin (105). The localization of Rp L7/L12 was on the surface of Streptococcus 
pyogenes (106, 107), which was immunogenic in human (108). In lactic acid bacteria, 
Rp L2, L16, S9, and S13 were identified as surface-associated proteins in L. 
rhamnosus GG cells with 5M LiCl treatment (65). Although the possible function of 
Rps on bacterial surface needs further investigation, the Rps with specific binding to 
acidic residues were identified in this study. Rp L12 of Neisseria gonorrhoeae was 
reported to be membrane-associated and involved in invasion of human reproductive 
cells (109). Rp p40/laminin-binding protein appeared to be engaged in cell adhesion 
(110), suggesting the surface Rps may serve as adhesin when attaching to the host. 
Commensal bacteria and pathogens use adhesins to attach to their host, evade 
immune defense, and invade to the epithelial tissue, as well as to cause disease in the 
host (111). After adherence, some of them also alter the mucus in the environment to 
increase their motility (112), degrade the mucus to use the glycoproteins as energy 
source (113), and disrupt the tight junction to access underlying tissues (114). 
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However, the adhesin studies show different approaches that have been taken to 
inhibit the adhesion of pathogen, in which adhesins may be therapeutic targets and 
vaccine candidates. Some studies designed competitive inhibitors based on detailed 
information from the adhesin-ligand interaction to prevent the adherence of bacteria 
(115, 116). A mucus-binding protein was constructed to express on the surface of 
lactobacilli as a marker for the diagnosis of colonic mucinous carcinomas (46). In this 
chapter, the adhesin-like components from the cell surface proteins of L. gasseri 
OLL2877 were identified, which showed high binding abilities to sHCM and acidic 
residues. Since the acidic residues are possible binding sites for enteric pathogens, 
OLL2877 strain would be expected for competitive exclusion of bacteria via acidic 
residues receptors through the five adhesin-like components in human GI tract. 
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CHAPTER 5 
General summary 
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Chapter 1: Introduction 
Probiotics are of significant importance to food and health industries due to their 
health-promoting effects when consumed. Studies have documented probiotic effects 
on dysbiosis, acute diarrhea, IBD, IBS, colon cancer, vaginal infection, allergy, and 
eradication of Helicobacter pylori. For the purpose of being sufficient host-interaction 
to confer health benefits, adhesion ability to the host gut has been considered as one 
of the selection criteria for probiotics strains.  
The expression of acidic residues in human colonic mucin is proposed to associate 
with the adhesion of gut microflora. Thus, the adhesion of probiotics to acidic 
residues in human colonic mucin was investigated in this study. 
 
Chapter 2: New screening methods for probiotics with adhesion properties to 
acidic residues in human colonic mucin using the Biacore assay 
Mucin, the major protein component of the intestinal mucus layer, can be divided 
into neutral and acidic mucin. The acidic residues (Neu5Ac and sulfate) binding to the 
sugar chain of mucin are proposed to protect colon mucin against enzymatic digestion 
from microflora. Since increased acidic mucin and increased bacterial concentration 
were both observed along the human colon, the acidic residues are proposed to act as 
adhesion site for microflora in the intestine. To evaluate the binding of acidic mucin 
and bacteria, a new screening method was constructed using the Biacore adhesion 
assay. 
The soluble human colonic mucin (sHCM) was prepared. Crude mucus scraped 
from the human colon tissue was digested with Proteinase K. After purified by gel 
filtration chromatography, the fractions containing high concentrations of sugars and 
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peptides were collected as sHCM, which was then immobilized on a CM5 sensor chip 
in the Biacore system. The removal of Neu5Ac and sulfate residues were performed 
using sialidase and sulfatase, respectively. Blockage of sulfate was performed using 
barium chloride (BaCl2).  
In the previous studies from my laboratory, several Lactobacillus and 
Bifidobacteria strains isolated from human feces were found to bind to human colonic 
mucin (HCM). Here I used 10 strains of lactobacilli and three strains of bifidobacteria 
that adhered to HCM strongly; and were selected to measure the binding to sHCM. 
Consequently, Lactobacillus strain OLL2785, L. gasseri OLL2877, and 
Bifidobacteria bifidum MCC1092 showed significantly higher adhesion than others (p 
< 0.01), so the three bacterial strains were selected to investigate further. After the 
removal of Neu5Ac from sHCM, the adhesion abilities of the three strains were 
decreased significantly (p < 0.05). However, the adhesion abilities of three strains 
were different after sulfatase treatment. L. gasseri OLL2877 showed a significant 
decrease after removing sulfate residues in sHCM, whereas the adhesion of OLL2785 
strain and B. bifidum MCC1092 increased (p < 0.05). To further clarify the binding of 
sulfate residue in sHCM and bacteria, sHCM was treated with barium chloride to 
block the electric charge of the sulfate. Results showed a significant decrease in 
adhesion after barium chloride treatment (p < 0.05).  
Accordingly, the Neu5Ac residue was recognized as a binding site by the three 
bacteria. OLL2785 strains and B. bifidum MCC1092 may have some adherence 
properties to sulfate, but they may have more binding abilities to Gal or GlcNAc 
exposed after sulfatase digestion than to the sulfate residue. Only L. gasseri OLL2877 
showed a significant decrease after both sulfatase and barium chloride treatment, 
suggesting OLL2877 has a strong adhesion to the sulfate expressed in sHCM. 
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Chapter 3:	  Analysis of surface proteins from probiotics with adhesion properties 
to acidic residues using the Biacore assay 
To further analyze the adhesive properties of bacterial surface proteins from the 
three selected bacteria to Neu5Ac and sulfate residues, the binding of bacterial surface 
proteins and the biotinylated probes with/without acidic residues were determined 
using the Biacore adhesion assay. Also, OLL2785 strain was identified as L. 
fornicalis in species level identification using 16S rRNA gene sequence. 
The cell surface proteins from the three bacteria were collected by washing the 
bacterial cell body three times with PBS (PBS wash fraction) and incubating in GHCl 
solution (GHCl-extracted fraction). The adhesion values of untreated bacterial cells 
were significantly higher than that of GHCl-treated bacterial cells, suggesting the 
adhesin-like components were removed by GHCl solution. In both OLL2785 and 
OLL2877 strains, the bindings of the GHCl fraction to sHCM was significantly higher 
than the PBS wash fraction (p < 0.01), but MCC1092 showed a contrary result that 
the adhesion of PBS wash fraction was higher. It suggests that the adhesin-like 
components on bacterial surface of MCC1092 were washed off by PBS. However, the 
adhesin-like components from OLL2785 and OLL2877 were extracted by GHCl 
solution, and showed higher adhesion to sHCM than MCC1092. 
The binding of GHCl fraction to the probes containing acidic probes (Gal-3-S, 
GlcNAc-6-S, and Neu5Ac) was also determined. The adhesion values of 2M GHCl 
fractions to the acidic residues were significantly higher than that of the PBS fractions 
(p < 0.01). Among different probes, the GHCl fractions of OLL785 and OLL2877 
showed higher binding to sulfate residues (Gal-3-S and GlcNAc-6-S) than to Neu5Ac, 
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suggesting the adhesin-like components from OLL2785 and OLL2877 recognized 
sulfate more than Neu5Ac. However, there was no significant difference in MCC1092. 
By comparing the binding to Gal-3-S/GlcNAc-6-S and the corresponding negative 
control Gal/GlcNAc, the effect of sulfate residue on adhesion could be clarified. Still, 
there was no significant difference in MCC1092. In OLL2785 and OLL2877 strains, 
the adhesion values of 2M GHCl fractions to acidic probes (Gal-3-S and GlcNAc-6-S) 
were significantly higher than to the probes without acidic residues (Gal and GlcNAc). 
Interestingly, though the binding to Gal-3-S was significantly higher than that to 
GlcNAc-6-S, the binding to Gal was lower than that to GlcNAc. It suggests that the 
higher binding to Gal-3-S was not contributed by the different monosaccharide linked 
to sulfate, but the whole structure of Gal-3-S may be recognized by adhesin-like 
components from OLL2785 and OLL2877.  
 
Chapter 4: Detection and identification of adhesin-like components from 
probiotics with specific affinity to sulfate residue in human colonic mucin 
After the binding of cell surface proteins of three selected strains and acidic 
residues was analyzed using the Biacore adhesion assay, I tried to detect the surface 
components of the selected strains by the binding to Gal-3-S probe in situ, and 
identify the adhesin-like molecules from OLL2877, which showed the highest 
adhesive abilities to sHCM and acidic residues, using receptor overlay and N-terminal 
amino acid sequencing analyses. 
In the indirect fluorescent labeling of cell surface components of bacteria, the 
bacterial smears were fixed on slide glasses and incubated with the Gal-3-S 
biotinylated probe, which was detected by Alexa Fluor 488 streptavidin conjugate 
(green) later. The nucleic acid of bacteria was stained by DAPI. Under fluorescence 
	   107 
microscope, the Gal-3-S-binding components of the selected strains were observed. 
The Gal-3-S-binding signal was overlaid with the DNA signal OLL2785, suggesting 
the Gal-3-S-binding components were contained on the surface of OLL2785 cell body. 
However, most of the Gal-3-S-binding components were around the bacterial cell 
body of OLL2877. It may indicate the bond strength of the adhesin-like components 
was weaker in OLL2877 than in OLL2785, thus they were released from OLL2877. 
By analyzing the fluorescence images, the green signals were quantified and 
normalized by counting the particle number of DAPI signals. The fluorescent area per 
cell of OLL2877 was significantly higher than that of OLL2785 and MCC1092, 
showing similar results to the Biacore adhesion assay to sHCM and acidic residues. 
Using receptor overlay analysis with different probes, the molecules with specific 
binding to different probes were detected. In the same bacterial strain, similar patterns 
were generally observed when the bands were detected by different sulfate probes, 
suggesting the adhesin-like molecules recognized by Gal-3-S or GlcNAc-6-S were 
almost identical. However, the molecules detected by Neu5Ac probe were totally 
different from sulfate probes, and fewer than that detected by sulfate probes.  
Since the surface proteins from OLL2877 showed the highest adherence to sHCM 
and acidic residues, the components (at 64, 63, 34, 29, and 27 kDa) from OLL2877 
specifically binding to Gal-3-S were further identified by sequencing the ten amino 
acids from the N-terminal end of each component. Compared to the database, the 64-
kDa and 63-kDa proteins showed 78% and 60% identity with pyruvate kinase, 
respectively. The 34-kDa and 28-kDa proteins showed 100% and 90% identity with 
50S ribosomal protein L2 and L3, respectively. Finally, the 27-kDa protein showed 
88% identity with 30S ribosomal protein S3. Accordingly, the intracellular proteins 
were expressed on the cell surface of L. gasseri OLL2877, which are proposed to 
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contribute to the extremely higher adhesion of L. gasseri OLL2877 to the acidic 
residues linked to the sugar chain of intestinal mucin. 
 
According to the results from this study performed for the purpose of investigating 
the adhesion properties of probiotics to acidic residues in human colonic mucin, the 
following conclusions were organized. 
(1)  A new screening method was developed using the Biacore assay to search for 
high-adhesive probiotics to Neu5Ac and sulfate residues of human colonic mucin. 
Three probiotics were found that recognized acidic residues. 
(2)  In quantitative analysis, the cell surface proteins from L. fornicalis OLL2785 and 
L. gasseri OLL2877 showed higher binding to sulfate residue than to Neu5Ac, 
and specifically recognized the whole structure of Gal-3-S. 
(3)  In qualitative analysis, the cell surface proteins binding to Gal-3-S were identical 
with the components from the same strain binding to GlcNAc-6-S, but were 
different from that binding to Neu5Ac. 
(4)  Pyruvate kinase and some ribosomal proteins expressed on the cell surface of L. 
gasseri OLL2877 are proposed to contribute to its high adhesion abilities to the 
acidic residues of intestinal mucin. 
 
In this study, the binding of intestinal bacteria and the acidic residues of mucin was 
investigated. A new evaluation system modified from the Biacore adhesion assay is 
provided for the selection of probiotics, which may also help researchers understand 
the adhesion strategies of bowel disease pathogens and microflora in the digestive 
tract. The different adhesion abilities to Neu5Ac and sulfate residues showed a 
variation in adhesion strategy among microbes. Since the acidic residues are possible 
	   109 
binding sites for enteric pathogens, L. gasseri OLL2877 would be expected for 
competitive exclusion of bacteria via acidic residue receptors through the adhesin-like 
components in human intestine. 
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